Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?

Taylor and Francis Group, Clinical and Experimental Hypertension, 5(39), p. 441-447, 2017

Journal article published in 2017 by Miguel Castillo-Sánchez

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving forbidden

Policy details

Data provided by